Eva Villamón

1.3k total citations
32 papers, 722 citations indexed

About

Eva Villamón is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, Eva Villamón has authored 32 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Infectious Diseases. Recurrent topics in Eva Villamón's work include Neuroblastoma Research and Treatments (10 papers), Antifungal resistance and susceptibility (8 papers) and Acute Myeloid Leukemia Research (6 papers). Eva Villamón is often cited by papers focused on Neuroblastoma Research and Treatments (10 papers), Antifungal resistance and susceptibility (8 papers) and Acute Myeloid Leukemia Research (6 papers). Eva Villamón collaborates with scholars based in Spain, Sweden and United States. Eva Villamón's co-authors include Daniel Gozalbo, M. Luisa Gil, Patricia Roig, José‐Enrique O’Connor, D Fradelizi, Celia Murciano, Rosa Noguera, Samuel Navarro, Irene Tadeo and Ana P. Berbegall and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Eva Villamón

30 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Villamón Spain 16 253 232 220 203 144 32 722
Torsten Giesemann Germany 14 548 2.2× 137 0.6× 300 1.4× 442 2.2× 47 0.3× 19 1.1k
Catherine L. Kennedy Australia 13 258 1.0× 74 0.3× 319 1.4× 261 1.3× 46 0.3× 17 851
Chi Wai Yip Hong Kong 18 297 1.2× 236 1.0× 80 0.4× 214 1.1× 43 0.3× 36 718
Hanjun Zhao Hong Kong 15 457 1.8× 311 1.3× 171 0.8× 406 2.0× 41 0.3× 31 1.0k
Mauro Bombaci Italy 13 341 1.3× 296 1.3× 82 0.4× 283 1.4× 26 0.2× 29 819
Bradley M. Mitchell United States 16 188 0.7× 215 0.9× 162 0.7× 107 0.5× 17 0.1× 25 733
Raghuram Koganti United States 16 133 0.5× 241 1.0× 117 0.5× 212 1.0× 31 0.2× 36 764
Chris Parsons United States 24 248 1.0× 306 1.3× 242 1.1× 678 3.3× 27 0.2× 40 1.3k
Nadine M. Turza Germany 10 254 1.0× 191 0.8× 589 2.7× 266 1.3× 28 0.2× 12 1.0k
Henry Ogbomo Canada 17 166 0.7× 194 0.8× 381 1.7× 182 0.9× 21 0.1× 28 774

Countries citing papers authored by Eva Villamón

Since Specialization
Citations

This map shows the geographic impact of Eva Villamón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Villamón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Villamón more than expected).

Fields of papers citing papers by Eva Villamón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Villamón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Villamón. The network helps show where Eva Villamón may publish in the future.

Co-authorship network of co-authors of Eva Villamón

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Villamón. A scholar is included among the top collaborators of Eva Villamón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Villamón. Eva Villamón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mora, Elvira, Rafael Hernani, José Cervera, et al.. (2025). Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome. Journal of Molecular Diagnostics. 27(6). 431–437.
2.
3.
López‐Guerra, Mònica, Eva Villamón, Francesca Guijarro, et al.. (2023). A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition. Leukemia & lymphoma. 65(3). 394–398.
4.
Navarro, Blanca, Carlos Solano, Marisa Calabuig, et al.. (2019). Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples. Anticancer Research. 39(9). 4757–4766. 3 indexed citations
5.
Navarro, Blanca, Eva Villamón, Carlos Solano, et al.. (2018). Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H- DNMT3A mutated clone of patient origin. Experimental and Molecular Pathology. 105(1). 139–143. 2 indexed citations
6.
Villamón, Eva, et al.. (2018). Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines. Cancer Cell International. 18(1). 15–15. 20 indexed citations
7.
Berbegall, Ana P., Eva Villamón, Marta Piqueras, et al.. (2015). Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors. Oncogene. 35(11). 1423–1432. 21 indexed citations
8.
Tadeo, Irene, Marta Piqueras, David Montaner, et al.. (2013). Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma. Pediatric Research. 75(2). 302–314. 16 indexed citations
9.
Villamón, Eva, Marta Piqueras, Ignácio Blanquer, et al.. (2013). NeuPAT: An intranet database supporting translational research in neuroblastic tumors. Computers in Biology and Medicine. 43(3). 219–228. 3 indexed citations
10.
Villamón, Eva, Ana P. Berbegall, Marta Piqueras, et al.. (2013). Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion. PLoS ONE. 8(1). e53740–e53740. 33 indexed citations
11.
Navarro, Samuel, Marta Piqueras, Eva Villamón, et al.. (2012). New prognostic markers in neuroblastoma. Expert Opinion on Medical Diagnostics. 6(6). 555–567. 4 indexed citations
12.
Castel, Victoria, Eva Villamón, Adela Cañete, et al.. (2010). Neuroblastoma in adolescents: genetic and clinical characterisation. Clinical & Translational Oncology. 12(1). 49–54. 30 indexed citations
13.
Noguera, Rosa, Eva Villamón, Ana P. Berbegall, et al.. (2010). Gain of MYCN Region in a Wilms Tumor-derived Xenotransplanted Cell Line. Diagnostic Molecular Pathology. 19(1). 33–39. 8 indexed citations
14.
Villamón, Eva, Marta Piqueras, Carlos Mackintosh, et al.. (2008). Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 453(1). 47–55. 17 indexed citations
15.
Herrera, Guadalupe, et al.. (2006). Cytomics: A multiparametric, dynamic approach to cell research. Toxicology in Vitro. 21(2). 176–182. 30 indexed citations
16.
Murciano, Celia, Eva Villamón, Daniel Gozalbo, et al.. (2006). Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility toCandida albicansin a model of hematogenously disseminated infection. Medical Mycology. 44(2). 149–157. 38 indexed citations
17.
Gozalbo, Daniel, Patricia Roig, Eva Villamón, & M. Luisa Gil. (2004). Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy. PubMed. 4(2). 117–135. 58 indexed citations
18.
Villamón, Eva, Daniel Gozalbo, Patricia Roig, et al.. (2004). Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis. Microbes and Infection. 6(6). 542–548. 39 indexed citations
19.
Villamón, Eva, Patricia Roig, M. Luisa Gil, & Daniel Gozalbo. (2004). Toll-like receptor 2 mediates prostaglandin E2 production in murine peritoneal macrophages and splenocytes in response to Candida albicans. Research in Microbiology. 156(1). 115–118. 20 indexed citations
20.
Villamón, Eva, Daniel Gozalbo, Patricia Roig, et al.. (2003). Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes and Infection. 6(1). 1–7. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Giesemann Breakdown of academic impact, for papers by Catherine L. Kennedy Breakdown of academic impact, for papers by Chi Wai Yip Breakdown of academic impact, for papers by Hanjun Zhao Breakdown of academic impact, for papers by Mauro Bombaci Breakdown of academic impact, for papers by Bradley M. Mitchell Breakdown of academic impact, for papers by Raghuram Koganti Breakdown of academic impact, for papers by Chris Parsons Breakdown of academic impact, for papers by Nadine M. Turza Breakdown of academic impact, for papers by Henry Ogbomo
Rankless by CCL
2026